Abbott

GL Accountant

Taguig City, National Capital Region, Philippines

$60,000 – $80,000Compensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Accounting, FinanceIndustries

Requirements

Candidates should possess a Bachelor’s degree in Accounting or a related field, and have at least 5 years of experience as a General Ledger Accountant. Strong analytical and accounting skills are required, along with proficiency in financial reporting and reconciliation processes. Familiarity with multi-currency accounting and intercompany transactions is also necessary.

Responsibilities

The General Ledger Accountant will be responsible for preparing monthly financial reports, annual financial statements, and other internal and external reports, ensuring accuracy and timeliness. They will also prepare and post general ledger journal entries, calculate and post accruals and prepayments, reconcile inter-company accounts, prepare multi-currency bank reconciliations, conduct variance analysis, and provide information to management and other departments. Additionally, the role involves supporting the transition of functions to other locations, preparing corporate packages, and collaborating with external audit staff.

Skills

General Ledger
Financial Reporting
Reconciliation
Journal Entries
Accruals
Prepayments
Multi-Currency Accounting
Intercompany Transactions
Variance Analysis
Bank Reconciliation

Abbott

Healthcare solutions in diagnostics and devices

About Abbott

Abbott Laboratories focuses on improving health through various medical technologies and health solutions. The company operates in areas such as cardiovascular health, diabetes management, diagnostic testing, nutrition, and neuromodulation for chronic pain and movement disorders. Abbott's products include advanced medical devices and diagnostic tests that help healthcare professionals and patients manage health conditions effectively. For example, their cardiovascular technologies assist in heart health management, while diabetes care products enable accurate glucose monitoring without painful fingersticks. Unlike many competitors, Abbott emphasizes accessibility and affordability in its offerings, aiming to make life-changing technologies available to a broader audience. The company's goal is to positively impact global health and well-being, supported by a commitment to sustainability and a 2030 Sustainability Plan.

Key Metrics

Lake Bluff, IllinoisHeadquarters
1888Year Founded
IPOCompany Stage
HealthcareIndustries
10,001+Employees

Risks

Departure of key leader Dr. Adamson may affect Abbott's Heart Failure division.
Integration challenges with Medtronic could impact glucose monitor-insulin pump rollout.
Thermo Fisher's microfluidics expansion may increase competition for Abbott.

Differentiation

Abbott integrates continuous glucose monitoring with automated insulin delivery systems.
Abbott's microfluidic devices streamline diagnostic processes efficiently.
Abbott's neuromodulation products target specific nervous system areas for chronic pain relief.

Upsides

Microfluidic technology offers cost-effective solutions in diagnostics.
Strategic partnerships like Abbott-Medtronic enhance product offerings and market reach.
Significant investments indicate strong market confidence in Abbott's healthcare solutions.

Land your dream remote job 3x faster with AI